James Davis; Executive Chairman of the Board, President, Chief Executive Officer; Quest Diagnostics Inc Sam Samad ... of our novel PFAS forever chemicals test, which we launched a little over ...

SECAUCUS, N.J. (AP) — SECAUCUS, N.J. (AP) — Quest Diagnostics Inc. (DGX) on Tuesday reported first-quarter earnings of $220 million. On a per-share basis, the Secaucus, New Jersey-based ...

James Davis; Executive Chairman of the Board, President, Chief Executive Officer; Quest ... of advanced diagnostics tests that over time, move to broader adoption. For example, we saw impressive ...

Quest Diagnostics has a one year low of $134.05 and a one year high of $178.87. The company has a market cap of $19.39 billion, a P/E ratio of 22.59, a P/E/G ratio of 2.16 and a beta of 0.78.

Quest Diagnostics Trading Down 0.4 % NYSE DGX opened at $163.75 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.10 and a debt-to-equity ratio of 0.82. The firm has a 50 day ...

Quest Diagnostics posted first-quarter revenue growth ... Further, the additional test volume from the following collaborations reinforces Quest's cost advantage. Optum Health, the largest US ...

NEW YORK - Quest Diagnostics (NYSE:DGX) reported first quarter earnings that beat analyst estimates on Tuesday. The company’s stock fell over -3.61% in premarket trading following the release.

Labcorp and peer Quest Diagnostics have also benefited from deals ... acquisitions and partnerships and further expand our test menu in four strategic areas, including oncology, women's health ...

PHOENIX — Self-screenings for HPV are now being offered at Sonora Quest Laboratories in Arizona ... are able to self-collect samples to test for human papillomavirus (HPV), which is an infection ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

There was a mix-up regarding my appointment for blood testing this morning. I arrived on time for my appointment but the kiosk indicated no appointment scheduled. It was 10 minutes to 12 (office ...

Roche Diagnostics is looking to a new screening tool to help women learn in a more private way if they are at increased risk for cervical cancer—a self-collection test to identify HPV.